DD213218A5 - Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxymethyl)-guaninderivaten - Google Patents

Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxymethyl)-guaninderivaten Download PDF

Info

Publication number
DD213218A5
DD213218A5 DD82256251A DD25625182A DD213218A5 DD 213218 A5 DD213218 A5 DD 213218A5 DD 82256251 A DD82256251 A DD 82256251A DD 25625182 A DD25625182 A DD 25625182A DD 213218 A5 DD213218 A5 DD 213218A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
dihydroxy
propoxymethyl
hours
Prior art date
Application number
DD82256251A
Other languages
German (de)
English (en)
Inventor
Julien P Verheyden
John C Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23017790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD213218(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DD213218A5 publication Critical patent/DD213218A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DD82256251A 1981-05-21 1982-05-21 Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxymethyl)-guaninderivaten DD213218A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06267210 US4355032B2 (en) 1981-05-21 1981-05-21 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent

Publications (1)

Publication Number Publication Date
DD213218A5 true DD213218A5 (de) 1984-09-05

Family

ID=23017790

Family Applications (2)

Application Number Title Priority Date Filing Date
DD82256251A DD213218A5 (de) 1981-05-21 1982-05-21 Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxymethyl)-guaninderivaten
DD82240075A DD203052A5 (de) 1981-05-21 1982-05-21 Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD82240075A DD203052A5 (de) 1981-05-21 1982-05-21 Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben

Country Status (33)

Country Link
US (1) US4355032B2 (no)
EP (1) EP0066208B1 (no)
JP (2) JPS57203086A (no)
KR (1) KR890004663B1 (no)
AR (1) AR244227A1 (no)
AT (1) ATE15899T1 (no)
AU (1) AU572086B2 (no)
BR (1) BR8202931A (no)
CA (3) CA1305140C (no)
CS (4) CS235018B2 (no)
DD (2) DD213218A5 (no)
DE (1) DE3266644D1 (no)
DK (2) DK150304C (no)
ES (7) ES8404355A1 (no)
FI (1) FI73682C (no)
GR (1) GR76459B (no)
HK (1) HK67088A (no)
HU (2) HU188000B (no)
IE (1) IE53731B1 (no)
IL (1) IL65836A (no)
IN (1) IN156469B (no)
LU (1) LU88334I2 (no)
MY (1) MY8700793A (no)
NL (2) NL930022I1 (no)
NO (2) NO161740C (no)
NZ (1) NZ200691A (no)
PH (1) PH17975A (no)
PL (4) PL136004B1 (no)
PT (1) PT74934B (no)
RO (2) RO84860B (no)
SG (1) SG81687G (no)
SU (1) SU1176841A3 (no)
ZA (1) ZA823532B (no)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4508898A (en) * 1980-09-16 1985-04-02 Ogilvie Kelvin K Antiviral triazine compounds
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4507305A (en) * 1981-05-21 1985-03-26 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
EP0072027B1 (en) * 1981-08-11 1988-05-18 The Wellcome Foundation Limited Antiviral compounds
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
ZA83626B (en) * 1982-02-01 1983-12-28 Syntex Inc Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
ES8705889A1 (es) * 1984-12-12 1987-06-01 Syntex Inc Un metodo para preparar eteres alcaximetilicos y esteres alcoximetilicos de derivados de guananina.
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
CA2005815C (en) * 1988-12-19 1999-08-03 Wellcome Foundation Limited (The) Antiviral acyclic nucleoside derivatives
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
CN1040759C (zh) * 1993-06-23 1998-11-18 默里尔药物公司 作为抗病毒剂和抗肿瘤剂的碳－无环核苷衍生物
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
IN179493B (no) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
EP0976751A1 (en) * 1996-04-09 2000-02-02 Lupin Laboratories Limited A process for the isomerisation of an N-7 isomer into an N-9 isomer useful in the synthesis of acyclic nucleosides
US5852208A (en) * 1996-08-30 1998-12-22 Dixie Chemical Company, Inc. Method of producing compounds containing acyloxyalkoxy groups from alcohols
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
WO2004037263A1 (en) * 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Pharmaceutical compositions of ganciclovir
WO2004039808A2 (en) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
US7078524B2 (en) * 2002-11-22 2006-07-18 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
EP3025718A1 (en) 2003-01-14 2016-06-01 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
ITMI20031202A1 (it) * 2003-06-13 2004-12-14 Lyogen Ltd Forma di cristallina del ganciclovir
CA2537132A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Amorphous valganciclovir hydrochloride
JP4746866B2 (ja) * 2004-11-19 2011-08-10 Ｔｃｍ株式会社 キャリッジ用ガタ抑制装置
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
US20110059921A1 (en) * 2008-03-27 2011-03-10 Ektar Therapeutics Oligomer-Nitrogenous Base Conjugates
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
BRPI0922508A8 (pt) * 2008-12-23 2016-01-19 Pharmasset Inc Análogos de nucleosídeo
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
JP5793084B2 (ja) 2008-12-23 2015-10-14 ギリアド ファーマセット エルエルシー プリンヌクレオシドの合成
CN101851239B (zh) * 2009-04-03 2012-11-28 上海益威实业有限公司 一种更昔洛韦的回收方法
CN102858790A (zh) 2010-03-31 2013-01-02 吉利德制药有限责任公司 核苷氨基磷酸酯
US9550803B2 (en) * 2011-05-06 2017-01-24 University Of Southern California Method to improve antiviral activity of nucleotide analogue drugs
CN102627643B (zh) * 2012-04-10 2014-01-08 常州康丽制药有限公司 更昔洛韦的精制方法
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
US9505775B2 (en) * 2012-11-03 2016-11-29 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
CN103059023B (zh) * 2012-12-31 2015-09-30 浙江车头制药股份有限公司 一种制备更昔洛韦晶型ⅱ的方法
US9486530B1 (en) 2013-08-30 2016-11-08 Exela Pharma Sciences, LLC Ganciclovir compositions and related methods
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113476413B (zh) * 2021-08-09 2022-06-28 海南海灵化学制药有限公司 一种注射用更昔洛韦钠冻干粉的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
AU7938482A (en) * 1980-12-22 1982-07-20 Astra Lakemedel Aktiebolag Novel derivatives of guanine
EP0072027B1 (en) * 1981-08-11 1988-05-18 The Wellcome Foundation Limited Antiviral compounds

Also Published As

Publication number Publication date
HK67088A (en) 1988-09-02
ES8507549A1 (es) 1985-09-16
SU1176841A3 (ru) 1985-08-30
EP0066208A1 (en) 1982-12-08
BR8202931A (pt) 1983-05-03
AU8389282A (en) 1982-11-25
DK227782A (da) 1982-11-22
ES8500276A1 (es) 1984-11-01
AU572086B2 (en) 1988-05-05
JPH0529399B2 (no) 1993-04-30
PT74934A (en) 1982-06-01
NO161740B (no) 1989-06-12
ES512414A0 (es) 1984-05-01
ES524900A0 (es) 1985-11-16
PL236521A1 (en) 1984-01-02
IL65836A0 (en) 1982-08-31
CA1305140C (en) 1992-07-14
LU88334I2 (fr) 1994-09-09
DK150304C (da) 1988-01-04
AR244227A1 (es) 1993-10-29
CA1305139C (en) 1992-07-14
NL930022I1 (nl) 1993-05-03
NL930139I2 (nl) 1997-07-01
US4355032B2 (en) 1990-10-30
ES8505681A1 (es) 1985-06-16
IN156469B (no) 1985-08-10
US4355032B1 (no) 1983-06-14
ES529383A0 (es) 1986-05-16
ES520849A0 (es) 1984-11-01
ES533821A0 (es) 1985-06-16
FI73682C (fi) 1987-11-09
CA1305141C (en) 1992-07-14
FI73682B (fi) 1987-07-31
RO84860B (ro) 1984-10-30
ATE15899T1 (de) 1985-10-15
ES8606869A1 (es) 1986-05-16
FI821794A0 (fi) 1982-05-20
PT74934B (en) 1984-05-08
PL136332B1 (en) 1986-02-28
NZ200691A (en) 1986-11-12
DK149001C (da) 1988-11-28
JPH046195B2 (no) 1992-02-05
PL136004B1 (en) 1986-01-31
PH17975A (en) 1985-02-22
IL65836A (en) 1991-04-15
US4355032A (en) 1982-10-19
DD203052A5 (de) 1983-10-12
NO1994005I1 (no) 1994-07-29
PL242101A1 (en) 1984-07-16
DK504183D0 (da) 1983-11-03
ES8601204A1 (es) 1985-11-16
CS235018B2 (en) 1985-04-16
ZA823532B (en) 1983-03-30
ES8404355A1 (es) 1984-05-01
CS235043B2 (en) 1985-04-16
RO87387B (ro) 1985-08-31
KR890004663B1 (ko) 1989-11-24
DK504183A (da) 1983-11-03
DK149001B (da) 1985-12-16
CS235044B2 (en) 1985-04-16
NO161740C (no) 1989-09-20
IE821210L (en) 1982-11-21
PL136579B1 (en) 1986-02-28
HU188000B (en) 1986-03-28
MY8700793A (en) 1987-12-31
RO84860A (ro) 1984-09-29
SG81687G (en) 1989-07-07
ES524899A0 (es) 1985-09-16
DK150304B (da) 1987-02-02
EP0066208B1 (en) 1985-10-02
PL136637B1 (en) 1986-03-31
HU186514B (en) 1985-08-28
ES8701496A1 (es) 1987-01-01
KR830010112A (ko) 1983-12-26
DE3266644D1 (en) 1985-11-07
RO87387A (ro) 1985-08-31
JPH04217983A (ja) 1992-08-07
JPS57203086A (en) 1982-12-13
IE53731B1 (en) 1989-02-01
GR76459B (no) 1984-08-10
NO821676L (no) 1982-11-22
ES529384A0 (es) 1987-01-01
PL246770A1 (en) 1984-08-27
PL242100A1 (en) 1984-04-24
CS235042B2 (en) 1985-04-16
NL930139I1 (nl) 1993-11-01

Similar Documents

Publication Publication Date Title
DD213218A5 (de) Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxymethyl)-guaninderivaten
DE2611690C2 (no)
CH640534A5 (de) In 2- und 9-stellung substituierte 9h-adenine.
EP0496238A1 (de) Substituierte Benzoxazepine und Benzthiazepine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0217207B1 (de) In 6- und 9-Stellung substituierte 2-Aminopurine, ihre Verwendung, diese Purine enthaltende Arzneimittel und Verfahren zur Herstellung der Purine
EP0225433B1 (de) Hydroxyoxaalkylmelamine, Verfahren zu ihrer Herstellung und deren Verwendung
CH637363A5 (en) Process for preparing novel 2-aminotetralins
EP0086324B1 (de) Verfahren zur Herstellung von Ascorbinsäure
EP0341693A1 (de) Verfahren zur Herstellung von O-substituierten Hydroxylaminen
DE2462559B2 (de) 4-Oximino-l -oxa-3-thiacyclopentane und deren 3-Oxide bzw. 33-Dioxide sowie 3-Oximino-l-oxa-4-thiacycIohexane und deren 4-Oxide bzw. 4,4-Dioxide
EP0270929A2 (de) Substituierte Aminomethyl-5,6,7,8-tetrahydronaphtyl-oxy-essigsäuren, neue Zwischenprodukte, Verfahren zu ihrer Herstellung sowie ihre Verwendungin Arzneimitteln
DD292003A5 (de) Verfahren zum herstellen von 2-amino-oxazolin-verbindungen
EP0179408A2 (de) Neue Amidoalkylmelamine und Aminoalkylmelamine und Verfahren zu ihrer Herstellung
DE2624360A1 (de) Verfahren zur herstellung von gegebenenfalls substituiertem 3-phenoxybenzaldehyd
DE3906174A1 (de) Verfahren zur herstellung von d-mannosaminderivaten
EP0152598B1 (de) Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin, seine Verwendung zur Herstellung von 1-(3-Hydroxy-propyl)-1,4-diazepan und 1,4 Bis-[3-(3,4,5-trimethoxy-benzoyloxy)-propyl]-diazepan
EP0110202B1 (de) Verfahren zur Herstellung von Phenylethanolaminen
EP0152856A2 (de) N-acylierte 1-Alkylamino-1-desoxy-ketose-Derivate, Verfahren zur Herstellung und ihre Verwendung
CH616143A5 (no)
DE3830351A1 (de) Verfahren zur herstellung von (alpha)-aminoalkanolen
DE3118813A1 (de) Verfahren zur herstellung von n-(2-( ( ( 5-(dialkylamino)-methyl-2-furanyl)-methyl)- thioethyl)-n'-alkyl-2-nitro-1,1-ethendiaminen und ihre zwischenprodukte
DE2438077A1 (de) Verfahren zur herstellung von propanolaminderivaten und nach dem verfahren hergestellte propanolaminderivate
DE1695757C3 (de) Pyridinmethanolcarbamate und Verfahren zu deren Herstellung
AT284126B (de) Verfahren zur Herstellung neuer substituierter Aminopyrimidine und deren Salze und optisch aktiven Isomere
EP0101934A1 (de) Verfahren zur Herstellung von 1-(Halogenalkyl)-1,2,3,4-tetrahydro-beta-carbolinen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee